$CAPR Wait little flaw in your brilliant assessment kittyboy... There is a possible vacc IND slated for Q4 and this tiny little Covid 2nd clinical looking to close out and readout before 24 months boy wonder... That might move the stock a tad there kiddo. And (just in case you are new to small cap bio's) they tend to go up in p3's due to hedge and investor interest... once again... Great recap
9
2
2 Likes